BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantLoading investors…
Activity from announced rounds
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
Provides AI-driven revenue cycle operations for healthcare providers
Provides a non-human identity security platform to detect and remediate leaked secrets in code